Greenland Mines (NASDAQ: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 covering gene therapy technology exclusively licensed by the company’s Biotech Division for the treatment of neuromuscular diseases through expression of the human Klotho protein. The patent strengthens the intellectual property supporting Greenland Mines’ Klotho-based therapeutic platform and includes claims covering gene therapy constructs, neuronal and induced pluripotent stem cells, and viral and non-viral delivery systems.
The patent further supports development of its KLTO-202 program targeting amyotrophic lateral sclerosis (“ALS”) and other neuromuscular disorders. This intellectual property milestone is critical for Greenland Mines as it advances its biotech division alongside its mining operations. The company operates two divisions: Mining, focused on the Skaergaard Project in southeast Greenland and the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and Biotech, including Klotho’s KLTO-202 primary indication for ALS.
Greenland Mines’ strategy centers on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. The patent grant in Australia is a significant step for the company’s biotech division, as it provides exclusive rights to the Klotho gene therapy technology in a key market.
The announcement underscores the potential of the Klotho protein in treating neuromuscular diseases. Klotho is known for its anti-aging properties and has been studied for its role in protecting against neurodegenerative conditions. By securing this patent, Greenland Mines strengthens its position in the competitive gene therapy landscape, particularly for ALS, a devastating disease with limited treatment options.
Investors should note that forward-looking statements in this release involve risks and uncertainties, as detailed in the company’s filings with the SEC. The full press release is available at https://nnw.fm/PVbbH. For more information on Greenland Mines, visit their newsroom at https://ibn.fm/GRML.
